Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions
Neonatal sepsis is a major cause of infant mortality in developing countries because of delayed injectable treatment, making it urgent to develop noninjectable formulations that can reduce treatment delays in resource-limited settings. Ceftriaxone, available only for injection, needs absorption enha...
| Huvudupphovsmän: | , , , , , , , , , , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
American Society for Microbiology
2018
|